TY - JOUR
T1 - Genomic organization of the human KAI1 metastasis-suppressor gene
AU - Dong, Jin Tang
AU - Isaacs, William B.
AU - Barrett, J. Carl
AU - Isaacs, John T.
N1 - Funding Information:
Sequence data from this article have been deposited with the EMBL/GenBank Data Libraries under Accession Nos. U67266± U67274. This work was supported by Grant CA 58236. 1To whom correspondence should be addressed at Johns Hopkins Oncology Center, 422 North Bond Street, Baltimore, MD 21231. Telephone: (410) 955-7777. Fax: (410) 955-0840.
PY - 1997/4/1
Y1 - 1997/4/1
N2 - Decreased expression of the human KAI1 metastasis-suppressor gene is involved in the progression of human prostatic cancer and possibly lung and breast cancer. To evaluate the frequency of mutation and allelic loss during the progression of human cancer, as well as to determine the regulatory mechanism for the expression of the KAI1 gene in normal and cancerous tissues, we characterized the 5'-promoter region, exon/intron organization, and transcription initiation site of the human KAI1 gene. About 80 kb of DNA was identified as the human KAI1 gene, which contains 8 kb of 5'-region, 10 exons, 9 introns, and 8 kb of DNA following exon 10. The coding region starts in exon 3 and ends in exon 10. The size of intron 1 is 29 kb, which almost equals the sizes of all other introns combined. A CpG island is present in the 5'-promoter region and extends to exon 1 and intron 1. The promoter region has no TATA or CCAAT box but has many putative binding motifs for various transcription factors, including nine Sp1 sites and five AP2 sites. These results suggest a diverse regulatory mechanism for the expression of the KAI1 gene in human tissues. The transcription initiation site of the KAI1 gene is located 181 bp upstream of the first nucleotide of the translation initiation codon. Comparisons of gene structures between KAI1 and seven other members of the transmembrane 4 superfamily revealed that the splicing sites relative to the different structural domains of the predicted proteins are well conserved, suggesting that these genes are evolutionarily related and that they arose through gene duplication and divergent evolution.
AB - Decreased expression of the human KAI1 metastasis-suppressor gene is involved in the progression of human prostatic cancer and possibly lung and breast cancer. To evaluate the frequency of mutation and allelic loss during the progression of human cancer, as well as to determine the regulatory mechanism for the expression of the KAI1 gene in normal and cancerous tissues, we characterized the 5'-promoter region, exon/intron organization, and transcription initiation site of the human KAI1 gene. About 80 kb of DNA was identified as the human KAI1 gene, which contains 8 kb of 5'-region, 10 exons, 9 introns, and 8 kb of DNA following exon 10. The coding region starts in exon 3 and ends in exon 10. The size of intron 1 is 29 kb, which almost equals the sizes of all other introns combined. A CpG island is present in the 5'-promoter region and extends to exon 1 and intron 1. The promoter region has no TATA or CCAAT box but has many putative binding motifs for various transcription factors, including nine Sp1 sites and five AP2 sites. These results suggest a diverse regulatory mechanism for the expression of the KAI1 gene in human tissues. The transcription initiation site of the KAI1 gene is located 181 bp upstream of the first nucleotide of the translation initiation codon. Comparisons of gene structures between KAI1 and seven other members of the transmembrane 4 superfamily revealed that the splicing sites relative to the different structural domains of the predicted proteins are well conserved, suggesting that these genes are evolutionarily related and that they arose through gene duplication and divergent evolution.
UR - http://www.scopus.com/inward/record.url?scp=0031128066&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031128066&partnerID=8YFLogxK
U2 - 10.1006/geno.1997.4618
DO - 10.1006/geno.1997.4618
M3 - Article
C2 - 9126478
AN - SCOPUS:0031128066
SN - 0888-7543
VL - 41
SP - 25
EP - 32
JO - Genomics
JF - Genomics
IS - 1
ER -